Rodríguez RBN, Río TM, Padilla GCM, Barroso LR, Fernández ML, Molina SY, Torres GO, Cheon QM, González RL, Molina CC, Nápoles ÁA, Sureda MM, Avila BD

Language: Spanish
References: 24
Page: 1-14
PDF size: 366.03 Kb.

ABSTRACT

Objective: To determine the characteristics of the factors associated with diabetic retinopathy in patients aged 50 years and older in Cuba.
Methods: An epidemiological, descriptive, cross-sectional investigation was carried out, which took the rapid survey of avoidable blindness conducted in Cuba in 2016, which included diabetic retinopathy validated by the World Health Organization. A database was prepared where all diabetics were taken and patients with and without retinopathy were compared according to the associated factors.
Results: Age, sex and previous ophthalmologic examination did not show a difference between the two groups. In the diagnosis of diabetes the age was < 60 years; p< 0.001; OR: 2.10 (1.28 to 3.47); the time of evolution of the disease ≥ 10 years; p< 0.001; OR: 2.53 (1,72 to 3.73). Random blood glucose in capillary blood was ≥ 7.7 mmol / L; p< 0.001; OR: 2.74 (1.60 to 4.68) and the type of insulin treatment p< 0.001; OR: 4.53 (2.76 to 7.43).
Conclusion: It is concluded that in diabetics 50 years of age and older in Cuba, the risk of developing diabetic retinopathy is not associated with age, sex, or the annual fundus examination. The risk is increased if diabetes is diagnosed before 60 years old, if there is uncontrolled glycemia and if the disease is 10 years old and more.

REFERENCES

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes. Epid Nat. 2001;414(6865):782-7.

2. Barría F. Diabetes mellitus: Una epidemia mundial. Arch Chil Oftalmol. 2008;65(1):63-6.

3. International Diabetes Federation. IDF Diabetes Atlas. Brussels, Belgium: IDF Executive Office; 2015 [acceso:19/09/2017]. Disponible en: https://www.idf.org/our-activities/careprevention/ eye-health/eye-health-guide.html

4. International Diabetes Federation. IDF Diabetes Atlas. Brussels, Belgium: IDF Executive Office; 2017 [acceso:19/09/2017]. Disponible en: https://www.idf.org/our-activities/careprevention/ eye-health/eye-health-guide.html

5. Organización Mundial de la Salud. Informe mundial sobre el envejecimiento y la salud; 2015 [acceso:21/09/2017]. Disponible en: http://www.who.int

6. Federación Internacional de Diabetes. Plan mundial contra la diabetes 2011-2021; 2013 [acceso:19/09/2017]. Disponible en: https://www.idf.org/our-activities/advocacy awareness/resources-and-tools/129:global-diabetes-plan-2011-2021.html

7. Pita Fernández S, Valdés Cañedo FA. Determinación de factores pronósticos. Cad Atenc Prim. 1997;4:26-9.

8. Limburg H, Meester W, Kuper H, Polack S, International Centre for Eye Health. Evaluación rápida de la ceguera evitable. Londres, Reino Unido: London School of Hygiene and Tropical Medicine; 2011 [acceso:20/09/2017]. Disponible en: https://www.cehjournal.org/resources/raab/

9. Dineen B, Foster A, Faal H. A rapid methodology to assess the prevalence and causes of blindness and visual impairment. Ophthalmic Epidemiol. 2006;13(1):1-4.

10. ONEI. Anuario Estadístico de Cuba. Población 2016; 2017 [acceso: 23/08/2017]. Disponible en: http://www.one.cu/aec2016.htm

11. Tóth G, Szabó D, Sándor GL, et al. Diabetes and diabetic retinopathy in people aged 50 years and older in Hungary. Br J Ophthalmol. 2016;101(7):965-9.

12. Minderhoud J, Pawiroredjo JC, Bueno de Mesquita-Voigt AM, et al. Diabetes and diabetic retinopathy in people aged 50 years and older in the Republic of Suriname. Br J Ophthalmol. 2016;100(6):814-18.

13. Hajar S, Al Hazmi A, Wasli M, Mousa A, Rubiu M. Prevalence and causes of blindness and diabetic retinopathy in Southern Saudi Arabia. Saudi Med J. 2015;36(4):449–55.

14. Díaz Díaz O, Orlandi González N. Manual para el diagnóstico y tratamiento del paciente diabético a nivel primario de salud. Edición OPS/OMS; 2013.

15. Ministerio de salud Chileno. Guía clínica diabetes mellitus tipo 2. Santiago de Chile: MINSAL; 2010 [acceso: 22/10/2017]. Disponible en: http://files.sld.cu/pdvedado/files/2010/05/gpc-dm2-final.pdf

16. Barría F, Martínez F, Verdaguer J. Actualización de la guía clínica de retinopatía diabética para Latinoamérica. ICO-PAAO-IAPV; 2016 [acceso: 19/09/2017]. Disponible en: https://issuu.com/japhsion/docs/guia_clinica_rd_paao_ico_16_may_2017

17. Zatic T, Bendelic E, Paduca A, Rabiu M, Corduneanu A, GarabaA, et al. Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova. Br J Ophthalmol. 2015;99(6):832–6.

18. Al Ghamdi AH, Rabiu M, Hajar S, Yorston D, Kuper H, Polack S. Rapid assessment of avoidable blindness and diabetic retinopathy in Taif, Saudi Arabia. Br J Ophthalmol. 2012;96(9):1168–72.

19. Organización Panamericana de la Salud. La educación terapéutica: Programa Cubano de educación en diabetes. OPS; 2007 [acceso: 08/09/2017]. Disponible en: https://books.google.com/books?isbn=9275328420

20. Rabiu MM, Al Bdour MD, Abu Ameerh MA, Jadoon MZ. Prevalence of blindness and diabetic retinopathy in Northern Jordan. Eur J Ophthalmol. 2015;25(4):320-7.

21. Polack S, Yorston D, López-Ramos A, Lepe-Orta S, Martin Baia R, Alves L, et al. Rapid assessment of avoidable blindness and diabetic retinopathy in Chiapass, México. Ophthalmology. 2012;119:1033-40.

22. Ruta LM, Magliano DJ, LeMesurier R,Taylor HR, Zimmet PZ, Shaw JE. Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diab Med. 2013;30(4):387–98.

23. Antonetti D, Klein R, Gardner TW. Diabetic Retinopathy. N Engl J Med. 2012;366:1227– 39.

24. Rawal LB, Tapp RJ, Williams ED, Chan S, Oldenburg B. Prevention of type 2 diabetes and its complications in developing countries: a review. Int J Behav Med. 2012;19(2):121–33.